BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 59 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,749 | -1.5% | 79,000 | 0.0% | 0.00% | – |
| Q2 2023 | $77,902 | -3.9% | 79,000 | 0.0% | 0.00% | – |
| Q1 2023 | $81,050 | -86.8% | 79,000 | -86.3% | 0.00% | -100.0% |
| Q4 2022 | $612,712 | -1.2% | 575,000 | -8.0% | 0.00% | 0.0% |
| Q3 2022 | $620,000 | -9.4% | 625,000 | -9.3% | 0.00% | 0.0% |
| Q2 2022 | $684,000 | -31.7% | 689,000 | -30.9% | 0.00% | -50.0% |
| Q1 2022 | $1,002,000 | -21.7% | 997,000 | -17.9% | 0.00% | 0.0% |
| Q4 2021 | $1,280,000 | +48.3% | 1,214,000 | +45.2% | 0.00% | +100.0% |
| Q3 2021 | $863,000 | +9.4% | 836,000 | +10.6% | 0.00% | 0.0% |
| Q2 2021 | $789,000 | -64.3% | 756,000 | -65.6% | 0.00% | -75.0% |
| Q4 2017 | $2,207,000 | +81.3% | 2,200,000 | +83.3% | 0.00% | +100.0% |
| Q3 2017 | $1,217,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 16,298,000 | $15,340,000 | 1.64% |
| ZAZOVE ASSOCIATES LLC | 25,540,000 | $24,103,000 | 1.55% |
| PIER 88 INVESTMENT PARTNERS LLC | 3,030,000 | $2,844,000 | 1.36% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,184,000 | 1.12% |
| Sonora Investment Management, LLC | 7,100,000 | $6,681,214,000 | 1.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 43,256,000 | $40,793,000 | 0.80% |
| Opera Trading Capital | 10,000,000 | $9,370,000 | 0.72% |
| AQR Arbitrage LLC | 52,575,000 | $49,486,000 | 0.57% |
| Neuberger Berman Group LLC | 5,000,000 | $469,375,000 | 0.54% |
| CQS Cayman LP | 12,000,000 | $11,322,000 | 0.52% |